Research into Overweight spans multiple therapeutic approaches and trial phases.

47 total trials for this combination

Showing top 10 of 47 trials

Trials

NCT ID	Title	Status	Phase
NCT05803421	A Study of Daily Oral Orforglipron (LY3502970) Compared With Insulin Glargine in Participants With Type 2 Diabetes and Obesity or Overweight at Increased Cardiovascular Risk	COMPLETED	—
NCT02019264	A Study to Evaluate the Effect of Long-term Treatment With BELVIQ (Lorcaserin HCl) on the Incidence of Major Adverse Cardiovascular Events and Conversion to Type 2 Diabetes Mellitus in Obese and Overweight Subjects With Cardiovascular Disease or Multiple Cardiovascular Risk Factors	COMPLETED	PHASE4
NCT05929066	A Study of Retatrutide (LY3437943) in Participants Who Have Obesity or Overweight	ACTIVE_NOT_RECRUITING	PHASE3
NCT01428791	Reducing Disparities in Late Life Depression and Metabolic Syndrome	COMPLETED	NA
NCT05556512	A Study of Tirzepatide (LY3298176) on the Reduction on Morbidity and Mortality in Adults With Obesity	ACTIVE_NOT_RECRUITING	PHASE3
NCT03574597	Semaglutide Effects on Heart Disease and Stroke in Patients With Overweight or Obesity	COMPLETED	PHASE3
NCT07392190	A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin	RECRUITING	—
NCT01601704	Cardiovascular Outcomes Study of Naltrexone SR/Bupropion SR in Overweight and Obese Subjects With Cardiovascular Risk Factors (The Light Study)	TERMINATED	PHASE3
NCT07037433	Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity	RECRUITING	—
NCT07037433	Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity	RECRUITING	—

Related Pages

All Overweight trials All trials in Chicago, United States